Based on clinical trials with 240 adult
and pediatric patients (12+ years)
with EoE at Week 24


A Breakthrough
Treatment for EoE

Eosinophilic esophagitis (EoE) is a chronic condition that can damage the esophagus over time. People with EoE
have more inflammation than normal in the esophagus, leading to difficulty swallowing and other symptoms.

Pills, slurries, and food elimination diets may provide symptom relief.
DUPIXENT helps reduce EoE symptoms.

DUPIXENT targets an underlying source of inflammation, which is a cause of EoE
DUPIXENT is a weekly injectable treatment given under the skin (subcutaneous injection). It is not a steroid or immunosuppressant.

The First and only FDA-approved treatment option for EoE

DUPIXENT was studied in a pair of 24-week clinical trials with adults and pediatric patients aged 12-17 who weigh at least 88 lb (40 kg) with eosinophilic esophagitis (EoE), most of whom had a history of prior use of swallowed topical corticosteroids for the treatment of EoE.

Have a productive
Conversation With
Your Doctor

Our goal is for you or your loved one to get the most out of your visit to your doctor. Download this doctor discussion guide to help yourself have a productive conversation during your next visit.

Download your guide

DUPIXENT MyWay®
Copay Card

The DUPIXENT MyWay Copay Card may help eligible patients cover the out-of-pocket cost of DUPIXENT. If you’re eligible, you can sign up and your card will be sent via email. Terms & Restrictions apply.

DOWNLOAD THE PATIENT
BROCHURE

Looking for DUPIXENT information you can download or print out? Download the patient brochure to have on hand.

GET THE DUPIXENT PATIENT BROCHURE

DOWNLOAD

Find a specialist who
treats EoE

Use this Healthgrades™ tool to easily find
nearby
specialists with experience in
treating patients
suffering from
Eosinophilic Esophagitis (EoE).